Topic: letter of intent

A mentored translational or clinical sarcoma project supports a fellow developing an independent research career. Priority is given to immediate clinical applications, including predictive biomarker studies. The one-year award begins 1 July 2027. New applicants must submit a letter of intent by 12 November 2026 at 13:00 U.S. Eastern Time; the later full-application deadline is 15 March 2027.

One-year support for emerging or existing mathematical-sciences research networks. Activities may include focused meetings, workshops and research incubators. Proposals close October 1, 2026; no prior letter of intent is required. A Catalyst proposal may also serve as a CRG letter of intent, with independent evaluation.